962 related articles for article (PubMed ID: 30146910)
1. Microbial modulation of the gut microbiome for treating autoimmune diseases.
Balakrishnan B; Taneja V
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):985-996. PubMed ID: 30146910
[TBL] [Abstract][Full Text] [Related]
2. Role of Microbiome and Antibiotics in Autoimmune Diseases.
Vangoitsenhoven R; Cresci GAM
Nutr Clin Pract; 2020 Jun; 35(3):406-416. PubMed ID: 32319703
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota in autoimmunity: potential for clinical applications.
Kim D; Yoo SA; Kim WU
Arch Pharm Res; 2016 Nov; 39(11):1565-1576. PubMed ID: 27444041
[TBL] [Abstract][Full Text] [Related]
4. The microbiome in autoimmune diseases.
De Luca F; Shoenfeld Y
Clin Exp Immunol; 2019 Jan; 195(1):74-85. PubMed ID: 29920643
[TBL] [Abstract][Full Text] [Related]
5. Causal Relationship between Diet-Induced Gut Microbiota Changes and Diabetes: A Novel Strategy to Transplant Faecalibacterium prausnitzii in Preventing Diabetes.
Ganesan K; Chung SK; Vanamala J; Xu B
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30467295
[TBL] [Abstract][Full Text] [Related]
6. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
7. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
Bruneau A; Baylatry MT; Joly AC; Sokol H
Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
9. Leveraging diet to engineer the gut microbiome.
Wolter M; Grant ET; Boudaud M; Steimle A; Pereira GV; Martens EC; Desai MS
Nat Rev Gastroenterol Hepatol; 2021 Dec; 18(12):885-902. PubMed ID: 34580480
[TBL] [Abstract][Full Text] [Related]
10. Impact of the gut microbiome in cardiovascular and autoimmune diseases.
Weis M
Clin Sci (Lond); 2018 Nov; 132(22):2387-2389. PubMed ID: 30455339
[TBL] [Abstract][Full Text] [Related]
11. Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity.
Meng X; Zhou HY; Shen HH; Lufumpa E; Li XM; Guo B; Li BZ
Autoimmun Rev; 2019 May; 18(5):455-475. PubMed ID: 30844549
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiome.
Sidhu M; van der Poorten D
Aust Fam Physician; 2017; 46(4):206-211. PubMed ID: 28376573
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
14. The role of the gut microbiome in systemic inflammatory disease.
Clemente JC; Manasson J; Scher JU
BMJ; 2018 Jan; 360():j5145. PubMed ID: 29311119
[TBL] [Abstract][Full Text] [Related]
15. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Dysbiosis in, and Enteral Bacterial Therapies for, Systemic Autoimmune Diseases.
Marietta E; Mangalam AK; Taneja V; Murray JA
Front Immunol; 2020; 11():573079. PubMed ID: 33193357
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
18. Next generation probiotics: an overview of the most promising candidates.
Dudík B; Kiňová Sepová H; Greifová G; Bilka F; Bílková A
Epidemiol Mikrobiol Imunol; 2022; 71(1):48-56. PubMed ID: 35477270
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G; Ianiro G; Gasbarrini A
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
